Centiva Capital’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,590
Closed -$139K 1898
2024
Q4
$139K Sell
10,590
-16,127
-60% -$223K ﹤0.01% 1441
2024
Q3
$310K Buy
26,717
+5,124
+24% +$48.3K 0.01% 1559
2024
Q2
$163K Sell
21,593
-1,787
-8% -$14.8K ﹤0.01% 1751
2024
Q1
$235K Sell
23,380
-1,677
-7% -$15.6K 0.01% 1386
2023
Q4
$233K Buy
+25,057
New +$259K 0.01% 1338
2020
Q1
Sell
-11,264
Closed -$313K 808
2019
Q4
$313K Buy
+11,264
New +$282K 0.02% 551

Other funds holding MD

Centiva Capital's MD Position: Q1 2025 in Review

Centiva Capital sold out of Pediatrix Medical (MD) in Q1 2025, closing a stake of 10,590 shares — an estimated $139K sold.

Centiva Capital first reported a position in MD in Q4 2019 and held it in 6 quarters. The position peaked at $313K in Q4 2019. 241 funds tracked by Wall St. Rank hold MD as of Q1 2025.

  • Centiva Capital reported no remaining Pediatrix Medical position as of Q1 2025 after selling out during the quarter.
  • Centiva Capital sold 10,590 Pediatrix Medical shares in Q1 2025, an estimated $139K.
  • Centiva Capital first reported a position in Pediatrix Medical in Q4 2019 and held it in 6 quarters.
  • Centiva Capital's Pediatrix Medical position peaked at $313K in Q4 2019.
  • 241 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2025.

Based on Centiva Capital's 13F filing for Q1 2025, filed 15 May 2025.